Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PerkinElmer launches pre-eclampsia screening assay in EU

This article was originally published in Clinica

Executive Summary

PerkinElmer (Waltham, Massachusetts) has launched its DELFIA Xpress PlGF Assay in the EU, for the early detection of pre-eclampsia in pregnant women. It is the first placental growth factor assay kit designed to screen pregnant women for early-onset pre-eclampsia during their first trimester of pregnancy. The assay, designed for use with PerkinElmer’s DELFIA Xpress table-top clinical instrument, detects levels of placental growth factor (PlGF). Reduced maternal serum concentration of PlGF is seen in a high proportion of pregnancies that go on to develop pre-eclampsia. The assay is not yet available in the US or Canada.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts